<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00119886</url>
  </required_header>
  <id_info>
    <org_study_id>Bosex</org_study_id>
    <nct_id>NCT00119886</nct_id>
  </id_info>
  <brief_title>Botox on Vulvar Vestibulitis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The study seeks to evaluate the effect of botulinum toxin on vulvar vestibulitis (VVS) after
      local injection with Botox, a potential treatment to relieve patients of vulvar pain,
      reducing the need for painkillers, and improving the sexual quality of life of the patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vulvar vestibulitis (VVS) is characterized by pain confined to the vulvar vestibule that
      occurs upon touch and attempted introitus entry ( e.g. intercourse, tampon insertion), with
      minimal associated clinical findings.

      The aetiology of VVS is not well established and many variables have been associated with the
      condition, e.g. neuropathy secondary to inflammation.

      Injection of Botulinum Toxin is tested as a therapeutic option for this condition.

      A temporary paralytic effect on the surrounding skeletal muscle hypertonicity is seen and
      earlier in cases described as a successful treatment of pelvic floor dysfunction, dyspareunia
      and interstitial cystitis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2005</start_date>
  <completion_date type="Anticipated">June 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduce vulvar pain on a visual analogue scale (VAS).</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigate the effect on sexuality, quality of life, marital relationship, depression and need of analgesics</measure>
  </secondary_outcome>
  <enrollment>64</enrollment>
  <condition>Vulvar Vestibulitis</condition>
  <condition>Vulvar Diseases</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Vulvar vestibulitis

          -  Safe birth control

        Exclusion Criteria:

          -  Treated earlier with Botulinum toxin

          -  Ongoing vulvar infection

          -  Age&lt;18

          -  Skin disease

          -  Pregnancy

          -  Myasthenia gravis

          -  Amyotrophic lateral sclerosis (ALS)

          -  Diabetes

          -  Using:

               -  Calcium antagonists;

               -  Aminoglycosides;

               -  Magnesium sulfate;

               -  Systemic steroid treatment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Damsted Petersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christina Damsted Petersen</last_name>
    <phone>+45 35 45 74 11</phone>
    <phone_ext>85 89</phone_ext>
    <email>rh19386@rh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lene Lundvall</last_name>
    <phone>+35 45 35 45</phone>
    <phone_ext>50 31</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Damsted Petersen</last_name>
      <phone>+45 35 45 74 11</phone>
      <phone_ext>85 89</phone_ext>
      <email>rh19386@rh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lene Lundvall</last_name>
      <phone>+45 35 45 35</phone>
      <phone_ext>5031</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Christina Damsted Petersen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Damsted Petersen, MD</last_name>
      <phone>+35 45 35 45</phone>
      <phone_ext>8589</phone_ext>
      <email>rh19386@rh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Lene Lundvall</last_name>
      <phone>+35 45 35 45</phone>
      <phone_ext>5031</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Christina Damsted Petersen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.nva.org/</url>
  </link>
  <results_reference>
    <citation>Gunter J, Brewer A, Tawfik O. Botulinum toxin a for vulvodynia: a case report. J Pain. 2004 May;5(4):238-40.</citation>
    <PMID>15162347</PMID>
  </results_reference>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2005</study_first_submitted>
  <study_first_submitted_qc>July 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2005</study_first_posted>
  <last_update_submitted>April 18, 2007</last_update_submitted>
  <last_update_submitted_qc>April 18, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vulvar Vestibulitis</mesh_term>
    <mesh_term>Vulvar Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

